Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bio Protocol (BIO) vs Litecoin (LTC) Price & Performance

Bio ProtocolTrade
LitecoinTrade

Price performance (Past 24H)

Key statistics

Bio Protocol vs Litecoin — how do they compare? Bio Protocol trades at Rp515.4 (market cap Rp1,16T, Rp252,63M 24h volume), while Litecoin trades at Rp784,202 (market cap Rp60,35T, Rp2,81T 24h volume). The key difference: Litecoin is far larger — about 52× Bio Protocol's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 77,4M / 84M LTC (93%) for Litecoin. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Litecoin for 75 Days on average.

BIOLTC
Market Cap
Rp1,16TRp60,35T
Volume (24h)
Rp252,63MRp2,81T
Circulating Supply
2,2B / 3,3B BIO (68%)77,4M / 84M LTC (93%)
Typical Hold Time
16 Days75 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Bio Protocol

No Aura AI signal available yet.

Litecoin

Litecoin is trading at Rp785,791 with a market cap of Rp60.97 trillion, showing a bearish technical signal from moving averages while oscillators remain neutral. The current price hovers near support at S2 (Rp786,613), with key resistance at R1 (Rp804,837). On-chain metrics indicate 93% of max supply is circulating, with an average hold time of 75 days, suggesting moderate network holding behavior amid recent price pressure.

Overall outlook is cautious due to bearish momentum and lack of major protocol upgrades. Key opportunities include potential rebound from oversold conditions (RSI_6 at 31.55), while risks involve continued selling pressure and low volatility breakouts. Investors should monitor Bitcoin correlation and broader crypto market sentiment for directional cues.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

BIO
0% Buy100% Sell
Avg holding period · 16 Days
LTC
55% Buy45% Sell
Avg holding period · 75 Days

Top news

Latest headlines on both assets

About Bio Protocol

BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.

Read more on BIO

About Litecoin

Litecoin was launched in late 2011 by former Google and Coinbase engineer, Charlie Lee. It was designed to provide fast, secure and low-cost payments by leveraging the unique properties of blockchain technology. It also has a maximum supply of 84 million litecoins.

Read more on LTC